Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,385.00
+25.00 (0.57%)
At close: Oct 2, 2025
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 88.68 billion as of October 6, 2025. Its market cap has decreased by -17.05% in one year.
Market Cap
88.68B
Enterprise Value
105.63B
Revenue
167.81B
Ranking
n/a
PE Ratio
13.91
Stock Price
4,385.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 88.68B, an increase of 199.17%. That is a compound annual growth rate of 5.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 88.68B | -13.93% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | 176.87B | 118.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |